Xtx Topco LTD Relmada Therapeutics, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$2.45 - $4.22 $53,922 - $92,877	22,009 New	22,009 $91,000
Q2 2023 Aug 14, 2023	SELL	$2.22 - $3.54 $167,610 - $267,270	-75,500 Reduced 87.52%	10,767 $26,000
Q1 2023 May 12, 2023	SELL	$2.24 - $4.76 $96,588 - $205,251	-43,120 Reduced 33.33%	86,267 $194,000
Q4 2022 Feb 14, 2023	BUY	$2.17 - $35.84 $280,769 - $4.64 Million	129,387 New	129,387 $451,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $11.7M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.